Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-046091
Filing Date
2011-08-12
Accepted
2011-08-12 16:11:58
Documents
9
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT v229457_10q.htm 10-Q 837346
2 EXHIBIT 31.1 v229457_ex31-1.htm EX-31.1 14840
3 EXHIBIT 32.1 v229457_ex32-1.htm EX-32.1 6425
  Complete submission text file 0001144204-11-046091.txt   2817425

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT lixt-20110630.xml EX-101.INS 395200
5 XBRL TAXONOMY EXTENSION SCHEMA lixt-20110630.xsd EX-101.SCH 21044
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lixt-20110630_cal.xml EX-101.CAL 27019
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lixt-20110630_def.xml EX-101.DEF 62059
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE lixt-20110630_lab.xml EX-101.LAB 147007
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lixt-20110630_pre.xml EX-101.PRE 83275
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 000-51476 | Film No.: 111031528
SIC: 2834 Pharmaceutical Preparations